| Basics |
Abbott Laboratories
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
|
| IPO Date: |
December 24, 1981 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$229.64B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.58 | 0.86%
|
| Avg Daily Range (30 D): |
$1.52 | 1.18%
|
| Avg Daily Range (90 D): |
$1.52 | 1.19%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
5.66M |
| Avg Daily Volume (30 D): |
5.81M |
| Avg Daily Volume (90 D): |
5.5M |
| Trade Size |
| Avg Trade Size (Sh.): |
150 |
| Avg Trade Size (Sh.) (30 D): |
64 |
| Avg Trade Size (Sh.) (90 D): |
64 |
| Institutional Trades |
| Total Inst.Trades: |
95,737 |
| Avg Inst. Trade: |
$5.24M |
| Avg Inst. Trade (30 D): |
$14.8M |
| Avg Inst. Trade (90 D): |
$13.66M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
17 |
| Market Closing Trades |
| Avg Closing Trade: |
$51.65M |
| Avg Closing Trade (30 D): |
$167.28M |
| Avg Closing Trade (90 D): |
$148.46M |
| Avg Closing Volume: |
648.08K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$7.72
|
$.76
|
$5.28
|
|
Diluted EPS
|
$7.7
|
$.76
|
$5.26
|
|
Revenue
|
$ 42.34B
|
$ 10.36B
|
$ 10.97B
|
|
Gross Profit
|
$ 23.63B
|
$ 5.89B
|
$ 6.03B
|
|
Net Income / Loss
|
$ 13.5B
|
$ 1.33B
|
$ 9.23B
|
|
Operating Income / Loss
|
$ 7.13B
|
$ 1.69B
|
$ 1.91B
|
|
Cost of Revenue
|
$ 18.71B
|
$ 4.47B
|
$ 4.94B
|
|
Net Cash Flow
|
$ 284M
|
$ -1108M
|
$ 141M
|
|
PE Ratio
|
17.51
|
|
|
|
